Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia

BACKGROUND: Primaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficient (G6PDd) patient. There is a need for reliable point-of-care G6PD diagnostic tests. OBJECTIVES: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Wojnarski, Bertha, Lon, Chanthap, Sea, Darapiseth, Sok, Somethy, Sriwichai, Sabaithip, Chann, Soklyda, Hom, Sohei, Boonchan, Threechada, Ly, Sokna, Sok, Chandara, Nou, Samon, Oung, Pheaktra, Kong, Nareth, Pheap, Vannak, Thay, Khengheang, Dao, Vy, Kuntawunginn, Worachet, Feldman, Mitra, Gosi, Panita, Buathong, Nillawan, Ittiverakul, Mali, Uthaimongkol, Nichapat, Huy, Rekol, Spring, Michele, Lek, Dysoley, Smith, Philip, Fukuda, Mark M., Wojnarski, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994100/
https://www.ncbi.nlm.nih.gov/pubmed/32004348
http://dx.doi.org/10.1371/journal.pone.0228207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994100/
https://www.ncbi.nlm.nih.gov/pubmed/32004348
http://dx.doi.org/10.1371/journal.pone.0228207

Ejemplares similares